Home | Contact | Out of Town Patients

Out of Town Patients

Home | Contact | Out of Town Patients

Out Of Town Patients

At Source Healthcare, we understand the unique needs of out-of-town patients seeking specialized pain management care. Our team is dedicated to providing seamless support, from initial consultations to personalized treatment plans, ensuring that every aspect of your visit is carefully coordinated for a smooth and stress-free experience. We are committed to delivering top-tier medical care in a state-of-the-art facility.

How Our Out-of-Town Consultations Work

At Source Healthcare, we make out-of-town consultations as convenient as possible by offering virtual appointments via video or phone. This allows you to discuss your medical concerns with our team without immediate travel. During these consultations, we take the time to thoroughly understand your condition, review your medical history, and discuss potential treatment options. This ensures you receive a tailored treatment plan that aligns with your specific needs.

Once your treatment plan is established, we’ll work closely with you to coordinate every aspect of your visit, from scheduling procedures to helping you identify the necessary accommodations. You will receive detailed instructions on how to prepare for your procedure, including any pretreatment requirements and what to expect during recovery. Our team is dedicated to making your experience as seamless as possible. We’re here to support you and ensure that your visit to Source Healthcare is comfortable and stress-free.

Accommodations Available for All Requirements…

Located in the heart of Santa Monica, Source Healthcare is conveniently situated near numerous hotels that suit every need and budget. Whether you prefer a luxury stay or a more sensible option, you’ll find comfortable accommodations just a short distance from our facility. Our team is happy to assist with recommendations and arrangements to ensure your visit is as seamless and stress-free as possible.

ACOMMODATIONS

Why Visit Source Healthcare for Pain Management?

At Source Healthcare, we believe in treating more than just the symptoms of pain—we identify and address the root causes. Our facility is equipped with cutting-edge technology to deliver precise and effective minimally invasive treatments tailored to your unique needs. Our team of specialists uses innovative techniques to target the source of your discomfort, helping you lead an active life without having to rely on drugs or medications just to get through the day.

If you’re prepared to return to a pain-free, active life, schedule your consultation today.

310-574-2777

Schedule a
Consultation

BOOK NOW

References

1. Cohen SP, Bhatia A, Buvanendran A, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists Regional Anesthesia & Pain Medicine 2018;43:521-546.

2. Vadivelu N, Schermer E, Kodumudi V, Belani K, Urman RD, Kaye AD. Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):298-306. doi: 10.4103/0970-9185.168149. PMID: 27625475; PMCID: PMC5009833.

3. Sanacora G, Frye MA, McDonald W, et al. American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017;74:399–405.

4. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 2000;85:483–491.

5. Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med. 2012;13:263–269.

6. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91:177–187.

7. Eichenberger U, Neff F, Sveticic G, et al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg. 2008;106:1265–1273.

8. Kvarnström A, Karlsten R, Quiding H, Emanuelsson BM, Gordh T. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol Scand. 2003;47:868–877.

9. Kvarnström A, Karlsten R, Quiding H, Gordh T. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol Scand. 2004;48:498–506.

10. Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147:107–115.

11. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 1995;37:1080–1087.

12. Amr YM. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial. Pain Physician. 2010;13:245–249.

13. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol. 1995;24: 360–365.

14. Sorensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M. Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol. 1997;24:1615–1621.

15. Sigtermans MJ, van Hilten JJ, Bauer MC, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145:304–311.

16. Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache. 2017;57:276–282.

17. Nicolodi M, Sicuteri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res. 1995;15: 181–189.

18. Mercadante S, Arcuri E, Tirelli W, et al. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 2000; 20:246-52.

Out of Town Patients